文献速递肺结节与肺癌

多学科团队模式干预用于肺结节管理的系统评价与单臂荟萃分析

Systematic review and single-arm meta-analysis of the clinical value of multidisciplinary team-based multimodal interventions in pulmonary nodule management
RSS 订阅 · PubMed 高证据 · 肺结节与肺癌筛查 · 2026-07-28

该系统评价纳入10项观察性研究共7658例患者,其中8项用于核心荟萃分析,评估多学科团队(MDT)模式管理肺结节的价值。合并阳性预测值为0.766(95%CI 0.643-0.913),指南依从率为0.766(95%CI 0.386-0.945),肺癌诊断率为0.120(95%CI 0.053-0.210),早期(I-II期)肺癌占诊断病例的0.741(95%CI 0.422-0.918);定性合成提示MDT管理可能有助于减少不必要的良性结节切除。

要点

  • MDT管理肺结节的合并阳性预测值为0.766,指南依从率同为0.766。
  • 诊断病例中早期(I-II期)肺癌合并比例为0.741。
  • 定性证据提示MDT或可减少部分临床情境下不必要的良性结节切除。

核心结论

  • MDT肺结节管理项目在诊断相关指标与指南依从性方面报告了相对较好的结果。
  • 定性合成提示MDT管理可能有助于在特定临床情境下减少不必要的良性肺结节切除。

研究设计与样本

  • 遵循PRISMA声明并在PROSPERO注册的系统评价与单臂荟萃分析。
  • 检索PubMed、Embase、Web of Science、Scopus和Cochrane Library截至2025年12月的文献。
  • 纳入10项观察性研究共7658例患者,其中8项有完整结局数据用于核心荟萃分析。
  • 队列研究用NOS评价质量,具诊断评价特征的研究用QUADAS-2评价。

主要发现

  • MDT肺结节管理的合并阳性预测值为0.766(95%CI:0.643-0.913)。
  • 合并指南依从率为0.766(95%CI:0.386-0.945)。
  • 合并肺癌诊断率为0.120(95%CI:0.053-0.210)。
  • 诊断病例中早期(I-II期)肺癌的合并比例为0.741(95%CI:0.422-0.918)。

关键数值与推荐

  • 合并阳性预测值0.766(95%CI:0.643-0.913)。
  • 合并指南依从率0.766(95%CI:0.386-0.945)。
  • 合并肺癌诊断率0.120(95%CI:0.053-0.210)。
  • 早期(I-II期)肺癌占诊断病例比例0.741(95%CI:0.422-0.918)。

临床怎么用

  • 可参考MDT协作评估模式优化肺结节风险分层与随访决策。
  • 关注指南依从性作为MDT流程质量的评价指标。
  • 对拟手术的良性可疑结节,可结合MDT讨论减少不必要切除。

局限性

  • 纳入研究均为观察性研究,证据等级有限。
  • 部分合并指标异质性较大(如指南依从率置信区间较宽)。
  • 纳入研究数量较少(共10项,核心荟萃8项)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Front Oncol. 2026 Jun 29;16:1852140. doi: 10.3389/fonc.2026.1852140. eCollection 2026. ABSTRACT BACKGROUND: Pulmonary nodules are highly prevalent and exhibit substantial heterogeneity. Traditional single-discipline management has limitations in risk assessment and precise stratification. Multidisciplinary team (MDT)-based management, which integrates cross-specialty collaborative evaluation, has gradually emerged; however, its clinical value remains controversial and warrants comprehensive assessment through systematic review. METHODS: This study was conducted in strict accordance with the PRISMA statement and was registered on PROSPERO. A systematic literature search was performed in PubMed, Embase, Web of Science, Scopus, and the Cochrane Library for studies published up to December 2025. Two independent reviewers conducted literature screening, data extraction, and quality assessment. Observational studies involving MDT-based pulmonary nodule management were included. Cohort studies were evaluated using the Newcastle-Ottawa Scale (NOS), whereas studies with diagnostic evaluation characteristics were assessed using QUADAS-2. Statistical analyses were conducted using R software (version 4.4.2). Heterogeneity was assessed using the I² test, and either fixed-effects or random-effects models were applied to pool effect sizes. Subgroup analyses were performed to explore sources of heterogeneity, sensitivity analyses were conducted using a leave-one-out approach, and publication bias was assessed via funnel plots and Egger's test. RESULTS: A total of 10 observational studies involving 7,658 patients were included, among which 8 studies with complete outcome data were used for the core meta-analysis. The pooled positive predictive value (PPV) of MDT-based pulmonary nodule management was 0.766 (95% CI: 0.643-0.913). The pooled guideline adherence rate was 0.766 (95% CI: 0.386-0.945). The pooled lung cancer diagnosis rate was 0.120 (95% CI: 0.053-0.210), and the pooled proportion of early-stage (I-II) lung cancer among diagnosed cases was 0.741 (95% CI: 0.422-0.918). In addition, qualitative synthesis suggested that MDT-based management may contribute to reducing unnecessary benign pulmonary nodule resection in selected clinical settings. CONCLUSION: MDT-based pulmonary nodule management programs were associated with relatively favorable reported outcomes in diagnostic-related metrics and guideline adherence across included studies. Further well-designed compara

来源:PubMed 高证据 · 肺结节与肺癌筛查,查看原文。版权归原作者所有。

引用

  1. PubMed 高证据 · 肺结节与肺癌筛查:Systematic review and single-arm meta-analysis of the clinical value of multidisciplinary team-based multimodal interventions in pulmonary nodule management

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。